<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39457329</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Differences in COVID-19 Vaccination and Experiences among Patients with Hypertension in Colombia and Jamaica during the COVID-19 Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1356</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21101356</ELocationID><Abstract><AbstractText>During the COVID-19 pandemic, hypertensive patients had increased infection and healthcare disruption in many low- and middle-income countries (LMICs) with limited vaccine access. The objective of this report is to describe COVID-19 experiences and vaccination uptake among hypertensive patients in Colombia and Jamaica. A cross-sectional study of patients with hypertension was conducted in primary care clinics in both countries between 2021 and 2022. Trained interviewers used a telephone-administered questionnaire to assess COVID-19 experiences (infection, vaccination, and healthcare access). A total of 576 patients (68.5% female, mean age: 67.5 years) participated. Health service disruption affecting access to care was low (&lt;10%). Compared to Jamaica, more participants from Colombia reported testing positive for COVID-19, having family members or friends testing positive, losing family members or friends due to COVID-19, and being vaccinated. In logistic regression models, adjusted for age, sex, education, and rural/urban clinic status, fear of COVID-19 (OR 2.7, 95% CI: 1.2-6.1) and residence in Colombia (OR 5.9, 95% CI: 2.4-14.6) were associated with higher vaccination uptake. Disparities in access to COVID-19 testing and diagnosis may have influenced these country differences including fear of COVID-19 and vaccine uptake. Other factors need to be better understood to prepare for future pandemic responses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Jacqueline P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-5968-1179</Identifier><AffiliationInfo><Affiliation>Department of Community Health and Psychiatry, The University of the West Indies, Kingston 7, Jamaica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Siyi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9199-4538</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindsay</LastName><ForeName>Carene</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology Research Unit, Caribbean Institute for Health Research, The University of the West Indies, Kingston 7, Jamaica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Trevor S</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-2393-1452</Identifier><AffiliationInfo><Affiliation>Epidemiology Research Unit, Caribbean Institute for Health Research, The University of the West Indies, Kingston 7, Jamaica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Katherine T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Lopez</LastName><ForeName>Jose Patricio</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0001-8865-0929</Identifier><AffiliationInfo><Affiliation>Masira Research Institute, Universidad de Santander (UDES), Bucaramanga 680003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanza</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7062-3225</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Allison N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0002-4266-1830</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Makeda J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Center for Translation Research and Implementation Science, National Heart, Lung and Blood Institute (NHLBI), NIH, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonwe</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center for Translation Research and Implementation Science, National Heart, Lung and Blood Institute (NHLBI), NIH, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Mabel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8780-8904</Identifier><AffiliationInfo><Affiliation>Masira Research Institute, Universidad de Santander (UDES), Bucaramanga 680003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campo</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4843-197X</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Medicine and Health Science, Universidad de Santander (UDES), Valledupar 200001, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Jaramillo</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Masira Research Institute, Universidad de Santander (UDES), Bucaramanga 680003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulloch-Reid</LastName><ForeName>Marshall K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Epidemiology Research Unit, Caribbean Institute for Health Research, The University of the West Indies, Kingston 7, Jamaica.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>4UH3HL152373</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 Mar 26:2024.03.25.24304855. doi: 10.1101/2024.03.25.24304855</RefSource><PMID Version="1">38585840</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007563" MajorTopicYN="N" Type="Geographic">Jamaica</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Colombia</Keyword><Keyword MajorTopicYN="N">Jamaica</Keyword><Keyword MajorTopicYN="N">health services</Keyword><Keyword MajorTopicYN="N">healthcare</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457329</ArticleId><ArticleId IdType="pmc">PMC11507612</ArticleId><ArticleId IdType="doi">10.3390/ijerph21101356</ArticleId><ArticleId IdType="pii">ijerph21101356</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meng S., Unwin H.J.T., Dphil B., Ferguson N.M., Mishra S., Stadler T., Bhatt S., Lison A., Banholzer N., Sharma M., et al. Effectiveness assessment of non-pharmaceutical interventions: Lessons learned from the COVID-19 pandemic. Lancet Public Health. 2023;8:e311–e317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10036127</ArticleId><ArticleId IdType="pubmed">36965985</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Excess Mortality Collaborators Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399:1513–1536. doi: 10.1016/S0140-6736(21)02796-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujolar G., Oliver-Anglès A., Vargas I., Vázquez M.-L. Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review. Int. J. Environ. Res. Public Health. 2022;19:1749. doi: 10.3390/ijerph19031749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19031749</ArticleId><ArticleId IdType="pmc">PMC8834942</ArticleId><ArticleId IdType="pubmed">35162772</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez C., Gonzalez R., Donnay F., Leke R.G.F. Avoiding indirect effects of COVID-19 on maternal and child health. Lancet Glob. Health. 2020;8:e863–e864. doi: 10.1016/S2214-109X(20)30239-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30239-4</ArticleId><ArticleId IdType="pmc">PMC7252153</ArticleId><ArticleId IdType="pubmed">32413281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nour T.Y., Altintaş K.H. Effect of the COVID-19 pandemic on obesity and it is risk factors: A systematic review. BMC Public Health. 2023;23:1018. doi: 10.1186/s12889-023-15833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15833-2</ArticleId><ArticleId IdType="pmc">PMC10227822</ArticleId><ArticleId IdType="pubmed">37254139</ArticleId></ArticleIdList></Reference><Reference><Citation>da Luz Pádua Guimarães M.C., Coelho J.C., Dos Santos J., de Oliveira Higa C.B., Flórido C.F., Lee R.J.W., Paes G.S., da Silva G.V., Drager L.F., Pierin A.M.G. Adherence to antihypertensive treatment during the COVID-19 pandemic: Findings from a cross-sectional study. Clin. Hypertens. 2022;28:35. doi: 10.1186/s40885-022-00219-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40885-022-00219-0</ArticleId><ArticleId IdType="pmc">PMC9713116</ArticleId><ArticleId IdType="pubmed">36451199</ArticleId></ArticleIdList></Reference><Reference><Citation>Krousel-Wood M., Craig L.S., Peacock E., Zlotnick E., O’Connell S., Bradford D., Shi L., Petty R. Medication Adherence: Expanding the Conceptual Framework. Am. J. Hypertens. 2021;34:895–909. doi: 10.1093/ajh/hpab046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpab046</ArticleId><ArticleId IdType="pmc">PMC8457429</ArticleId><ArticleId IdType="pubmed">33693474</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza A.C.C., Borges J.W.P., Moreira T.M.M. Quality of life and treatment adherence in hypertensive patients: Systematic review with meta-analysis. Rev. Saude Publica. 2016;50:71. doi: 10.1590/s1518-8787.2016050006415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1518-8787.2016050006415</ArticleId><ArticleId IdType="pmc">PMC5152803</ArticleId><ArticleId IdType="pubmed">28099657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health and Wellness (MOHW) COVID-19 at a Glance.  [(accessed on 12 August 2024)];2022  Available online:  https://www.moh.gov.jm/wp-content/uploads/2022/05/MOH_CovidataGlance.pdf.</Citation></Reference><Reference><Citation>The Ministry of Health and Social Protection  Colombia Confirms Its First Case of COVID-19.  [(accessed on 12 August 2024)];2020  Available online:  https://www.minsalud.gov.co/English/Paginas/Colombia-Confirms-Its-First-Case-of-COVID-19.aspx.</Citation></Reference><Reference><Citation>Mathieu E., Ritchie H., Rodés-Guirao L., Appel C., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D., Ortiz-Ospina E., et al.  Coronavirus Pandemic (COVID-19) 2020.  [(accessed on 20 August 2024)].  Available online:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>United Nations  World Population Prospects. [Original Data] 2024.  [(accessed on 14 August 2024)].  Available online:  https://ourworldindata.org/grapher/population-unwpp.</Citation></Reference><Reference><Citation>MOHW and UWI . Jamaica Health &amp; Lifestyle Survey 111: Preliminary Finidings. MOHW and UWI; Kingston, Jamaica: 2018.</Citation></Reference><Reference><Citation>Barrera L., Gómez F., Ortega-Lenis D., Corchuelo Ojeda J., Méndez F. Prevalence, awareness, treatment and control of high blood pressure in the elderly according to the ethnic group. Colombian survey. Colombia Medica. 2019;50:115–127. doi: 10.25100/cm.v50i2.4124.</Citation><ArticleIdList><ArticleId IdType="doi">10.25100/cm.v50i2.4124</ArticleId><ArticleId IdType="pmc">PMC6774579</ArticleId><ArticleId IdType="pubmed">31607768</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Zuliani G., Rigatelli A., Mazza A., Roncon L. Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis. J. Infect. 2020;81:e84–e86. doi: 10.1016/j.jinf.2020.03.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.059</ArticleId><ArticleId IdType="pmc">PMC7151373</ArticleId><ArticleId IdType="pubmed">32283158</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie Z.G., Zewotir T. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis. 2021;21:855. doi: 10.1186/s12879-021-06536-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06536-3</ArticleId><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradpour J., Shajarizadeh A., Carter J., Chit A., Grootendorst P. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake. PLoS ONE. 2023;18:e0293184. doi: 10.1371/journal.pone.0293184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0293184</ArticleId><ArticleId IdType="pmc">PMC10621822</ArticleId><ArticleId IdType="pubmed">37917650</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehal K.R., Steendam L.M., Campos Ponce M., van der Hoeven M., Smit G.S.A. Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis. Vaccines. 2021;9:1071. doi: 10.3390/vaccines9101071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101071</ArticleId><ArticleId IdType="pmc">PMC8540052</ArticleId><ArticleId IdType="pubmed">34696179</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson E., Reeve K.S., Niedzwiedz C.L., Moore J., Blake M., Green M., Katikireddi S.V., Benzeval M.J. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav. Immun. 2021;94:41–50. doi: 10.1016/j.bbi.2021.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC7946541</ArticleId><ArticleId IdType="pubmed">33713824</ArticleId></ArticleIdList></Reference><Reference><Citation>NCSS, LLC  . PASS 2024 Power Analysis and Sample Size Software. NCSS, LLC; Kaysville, UT, USA: 2024.  [(accessed on 1 July 2021)].  Available online:  https://www.ncss.com/software/pass.</Citation></Reference><Reference><Citation>Newcombe R.G. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat. Med. 1998;17:857–872. doi: 10.1002/(SICI)1097-0258(19980430)17:8&lt;857::AID-SIM777&gt;3.0.CO;2-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(19980430)17:8&lt;857::AID-SIM777&gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">9595616</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleiss J., Levin B., Paik M. Statistical Methods for Rates and Proportions. 3rd ed. John Wiley &amp; Sons; Hoboken, NJ, USA: 2003.</Citation></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L., et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan American Health Organization  Colombia Receives the First Vaccines to Arrive in the Americas through the COVAX Facility.  [(accessed on 12 January 2024)].  Available online:  https://www.paho.org/es/noticias/1-3-2021-colombia-recibe-primeras-vacunas-que-llegan-americas-traves-mecanismo-covax.</Citation></Reference><Reference><Citation>Mexico Begins Covid Vaccine Rollout—The New York Times.  [(accessed on 16 May 2024)].  Available online:  https://www.nytimes.com/2020/12/24/world/americas/mexico-coronavirus-vaccine.html.</Citation></Reference><Reference><Citation>Alarcón-Braga E.A., Hernandez-Bustamante E.A., Salazar-Valdivia F.E., Valdez-Cornejo V.A., Mosquera-Rojas M.D., Ulloque-Badaracco J.R., Rondon-Saldaña J.C., Zafra-Tanaka J.H. Acceptance towards COVID-19 vaccination in Latin America and the Caribbean: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2022;49:102369. doi: 10.1016/j.tmaid.2022.102369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2022.102369</ArticleId><ArticleId IdType="pmc">PMC9169427</ArticleId><ArticleId IdType="pubmed">35680058</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuters Latest Updates: COVID-19 Vaccination Charts, Maps and Eligibility by Country. 2023.  [(accessed on 13 October 2023)].  Available online:  https://www.reuters.com/graphics/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/</Citation></Reference><Reference><Citation>Statista  COVID-19 Vaccine: Immunization Colombia 2023|Statista. 2023.  [(accessed on 13 October 2023)].  Available online:  https://www.statista.com/statistics/1288083/population-vaccinated-against-covid-19-colombia/</Citation></Reference><Reference><Citation>Zhu K., Ma S., Chen H., Xie J., Huang D., Ma G., Huang Y. Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China. Hum. Vaccines Immunother. 2023;19:2253599. doi: 10.1080/21645515.2023.2253599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2253599</ArticleId><ArticleId IdType="pmc">PMC10760500</ArticleId><ArticleId IdType="pubmed">37905728</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Jiang C., Wang J., Liu Y. The factors correlated with COVID-19 vaccination coverage in Chinese hypertensive patients managed by community general practitioner. Hum. Vaccines Immunother. 2023;19:2197839. doi: 10.1080/21645515.2023.2197839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2197839</ArticleId><ArticleId IdType="pmc">PMC10088921</ArticleId><ArticleId IdType="pubmed">37013839</ArticleId></ArticleIdList></Reference><Reference><Citation>Daungsupawong H., Wiwanitkit V. COVID-19 vaccination coverage in hypertensive patients with Omicron infection: Comments on factors. Hum. Vaccines Immunother. 2023;19:2285913. doi: 10.1080/21645515.2023.2285913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2285913</ArticleId><ArticleId IdType="pmc">PMC10760369</ArticleId><ArticleId IdType="pubmed">37991011</ArticleId></ArticleIdList></Reference><Reference><Citation>Patwary M.M., Alam M.A., Bardhan M., Disha A.S., Haque M.Z., Billah S.M., Kabir M.P., Browning M.H.E.M., Rahman M.M., Parsa A.D., et al. COVID-19 Vaccine Acceptance among Low- and Lower-Middle-Income Countries: A Rapid Systematic Review and Meta-Analysis. Vaccines. 2022;10:427. doi: 10.3390/vaccines10030427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10030427</ArticleId><ArticleId IdType="pmc">PMC8950670</ArticleId><ArticleId IdType="pubmed">35335059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens G., Lodder P., Smeets T., Duijndam S. Fear of COVID-19 predicts vaccination willingness 14 months later. J. Anxiety Disord. 2022;88:102574. doi: 10.1016/j.janxdis.2022.102574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janxdis.2022.102574</ArticleId><ArticleId IdType="pmc">PMC9047433</ArticleId><ArticleId IdType="pubmed">35512598</ArticleId></ArticleIdList></Reference><Reference><Citation>Chutiyami M., Salihu D., Bello U.M., Winser S.J., Gambo A.A., Sabo H., Kolo A.M., Jalo H.A., Muhammad A.S., Mahmud F.A., et al. Are Fear of COVID-19 and Vaccine Hesitancy Associated with COVID-19 Vaccine Uptake? A Population-Based Online Survey in Nigeria. Vaccines. 2022;10:1271. doi: 10.3390/vaccines10081271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081271</ArticleId><ArticleId IdType="pmc">PMC9415607</ArticleId><ArticleId IdType="pubmed">36016160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynter-Adams D., Thomas-Brown P. COVID-19 vaccine hesitancy in a developing country: Prevalence, explanatory factors and implications for the future. Public Health. 2023;217:146–154. doi: 10.1016/j.puhe.2023.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2023.01.031</ArticleId><ArticleId IdType="pmc">PMC9899772</ArticleId><ArticleId IdType="pubmed">36889053</ArticleId></ArticleIdList></Reference><Reference><Citation>CARPHA  COVID-19 Vaccine Acceptance among Active Social Media Users in the Caribbean. 2023.  [(accessed on 12 August 2024)].  Available online:  https://www.carpha.org/Portals/0/Publications/Summary Results of COVID-19 Vaccine Acceptance Survey.pdf.</Citation></Reference><Reference><Citation>Hussain B., Latif A., Timmons S., Nkhoma K., Nellums L.B. Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies. Vaccine. 2022;40:3413–3432. doi: 10.1016/j.vaccine.2022.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.04.030</ArticleId><ArticleId IdType="pmc">PMC9046074</ArticleId><ArticleId IdType="pubmed">35534309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajar J.K., Sallam M., Soegiarto G., Sugiri Y.J., Anshory M., Wulandari L., Kosasih S.A.P., Ilmawan M., Kusnaeni K., Fikri M., et al. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines. 2022;10:1356. doi: 10.3390/vaccines10081356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081356</ArticleId><ArticleId IdType="pmc">PMC9412456</ArticleId><ArticleId IdType="pubmed">36016242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Bai Y., Bai L., Wang N. The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients. Medicine. 2023;102:e33923. doi: 10.1097/MD.0000000000033923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000033923</ArticleId><ArticleId IdType="pmc">PMC10312365</ArticleId><ArticleId IdType="pubmed">37390289</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkilineni P., Simon R., Bhan A., Rao S.D. Patient Perspectives on the COVID-19 Vaccine: A Pilot Survey Study of Patients in Endocrinology Clinics. Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 2022;28:897–900. doi: 10.1016/j.eprac.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.06.010</ArticleId><ArticleId IdType="pmc">PMC9250825</ArticleId><ArticleId IdType="pubmed">35787467</ArticleId></ArticleIdList></Reference><Reference><Citation>Soomar S.M., Soomar S.M., Khan M., Moin G., Azam I. COVID-19 vaccine acceptance and hesitancy among the general population of Pakistan: A population-based survey. BMJ Open. 2022;12:e064096. doi: 10.1136/bmjopen-2022-064096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064096</ArticleId><ArticleId IdType="pmc">PMC9485645</ArticleId><ArticleId IdType="pubmed">36115670</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzieciolowska S., Hamel D., Gadio S., Dionne M., Gagnon D., Robitaille L., Cook E., Caron I., Talib A., Parkes L., et al. Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: A multicenter survey. Am. J. Infect. Control. 2021;49:1152–1157. doi: 10.1016/j.ajic.2021.04.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2021.04.079</ArticleId><ArticleId IdType="pmc">PMC8079260</ArticleId><ArticleId IdType="pubmed">33930516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewnard J.A., B C.M., Kang G., Laxminarayan R. Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city. Nat. Commun. 2023;14:3563. doi: 10.1038/s41467-023-39322-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39322-7</ArticleId><ArticleId IdType="pmc">PMC10272147</ArticleId><ArticleId IdType="pubmed">37322091</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombia Now Has Antigen Testing.  [(accessed on 13 October 2023)]; Available online:  https://www.minsalud.gov.co/English/Paginas/Colombia-Now-Has-Antigen-Testing.aspx.</Citation></Reference><Reference><Citation>Ministry of Health &amp; Wellness (Jamaica)  Jamaica to Offer Antigen Testing for COVID-19—Ministry of Health &amp; Wellness, Jamaica.  [(accessed on 13 October 2023)]; Available online:  https://www.moh.gov.jm/jamaica-to-offer-antigen-testing-for-covid-19/</Citation></Reference><Reference><Citation>PAHO/WHO  COVID-19 Situation Reports—Jamaica—PAHO/WHO | Pan American Health Organization [Internet]  [(accessed on 27 August 2024)].  Available online:  https://www.paho.org/en/covid-19-situation-reports-jamaica.</Citation></Reference><Reference><Citation>United Nations Population Fund World Population Dashboard -Colombia|United Nations Population Fund.  [(accessed on 13 October 2023)].  Available online:  https://www.unfpa.org/data/world-population/CO.</Citation></Reference><Reference><Citation>Johns Hopkins University &amp; Medicine  Colombia—COVID-19 Overview—Johns Hopkins.  [(accessed on 13 October 2023)].  Available online:  https://coronavirus.jhu.edu/region/colombia.</Citation></Reference><Reference><Citation>Johns Hopkins University &amp; Medicine  Jamaica—COVID-19 Overview—Johns Hopkins.  [(accessed on 13 October 2023)].  Available online:  https://coronavirus.jhu.edu/region/jamaica.</Citation></Reference><Reference><Citation>WHO  Noncommunicable Diseases: Mortality. 2023.  [(accessed on 13 October 2023)].  Available online:  https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-mortality.</Citation></Reference><Reference><Citation>World Health Organization  COVID-19 Significantly Impacts Health Services for Noncommunicable Diseases. 2020.  [(accessed on 13 October 2023)].  Available online:  https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.</Citation></Reference><Reference><Citation>Ochi S., Hodgson S., Landeg O., Mayner L., Murray V. Disaster-driven evacuation and medication loss: A systematic literature review. PLoS Curr. 2014;6 doi: 10.1371/currents.dis.fa417630b566a0c7dfdbf945910edd96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/currents.dis.fa417630b566a0c7dfdbf945910edd96</ArticleId><ArticleId IdType="pmc">PMC4169391</ArticleId><ArticleId IdType="pubmed">25642363</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Kendrick P.J., Paulson K.R., Gupta V., Abrams E.M., Adedoyin R.A., Adhikari T.B., Advani S.M., Agrawal A., Ahmadian E., et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 2020;8:585–596. doi: 10.1016/S2213-2600(20)30105-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30105-3</ArticleId><ArticleId IdType="pmc">PMC7284317</ArticleId><ArticleId IdType="pubmed">32526187</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah N.P., Clare R.M., Chiswell K., Navar A.M., Shah B.R., Peterson E.D. Trends of blood pressure control in the U.S. during the COVID-19 pandemic. Am. Heart J. 2022;247:15–23. doi: 10.1016/j.ahj.2021.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2021.11.017</ArticleId><ArticleId IdType="pmc">PMC8662834</ArticleId><ArticleId IdType="pubmed">34902314</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>